BioSante Pharma (BPAX) Misses Q2 EPS by 6c

July 25, 2011 4:18 PM EDT
BioSante Pharma (NASDAQ: BPAX) reported Q2 EPS of ($0.16), $0.06 worse than the analyst estimate of ($0.10).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings